Visceral fat as a main determinant of plasminogen activator inhibitor 1 level in women

被引:85
作者
Janand-Delenne, B
Chagnaud, C
Raccah, D
Alessi, MC
Juhan-Vague, I
Vague, P
机构
[1] Hop Univ Timone, Serv Nutr Endocrinol Malad Metab, Marseille, France
[2] Hop Univ Timone, Serv Radiol, Marseille, France
[3] Hop Univ Timone, Hematol Lab, Marseille, France
关键词
visceral fat; plasminogen activator inhibitor 1 (PAI-1); weight loss;
D O I
10.1038/sj.ijo.0800585
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
OBJECTIVE: To substantiate in a premenopausal population of women, the link between visceral adipose tissue and circulating plasminogen activator inhibitor 1 (PAI-1) levels. DESIGN: Study of correlations between anthropometric parameters and PAI-1 and evaluation of the changes induced by weight loss. SUBJECTS: Forty-two healthy pre-menopausal women (aged 18-51 y, with a wide range of body mass index (BMI, 21-48.8 kg/m(2)). Thirteen women were evaluated after weight loss (6.6 +/- 3.3 kg). MEASUREMENTS: BMI, waist and hip circumferences. Total, subcutaneous and visceral adipose tissue areas at the L3-L4 level by computed tomography. Insulin, cholesterol, triglyceride, HDL cholesterol, PAI-1 activity, PAI-1 antigen and tissue plasminogen activator (tPA) antigen. RESULTS: PAI-1 activity, PAI antigen and tPA antigen were positively correlated with visceral adipose tissue, but not with subcutaneous adipose tissue. This correlation was independent of insulin or triglyceride levels. The amount of visceral adipose tissue explained 28% of the PAI-1 activity variance. Weight loss confirmed this link, PAI-1 diminution being correlated only with visceral adipose tissue loss and not with total fat, insulin or triglyceride decrease. CONCLUSION: This study suggests, like in vitro studies, that visceral fat may be an important contributor to the circulating PAI-1.
引用
收藏
页码:312 / 317
页数:6
相关论文
共 36 条
  • [21] Elaboration of type-1 plasminogen activator inhibitor from adipocytes - A potential pathogenetic link between obesity and cardiovascular disease
    Lundgren, CH
    Brown, SL
    Nordt, TK
    Sobel, BE
    Fujii, S
    [J]. CIRCULATION, 1996, 93 (01) : 106 - 110
  • [22] PLASMINOGEN-ACTIVATOR INHIBITOR ACTIVITY IN VARIOUS TYPES OF ENDOGENOUS HYPERTRIGLYCERIDEMIA
    RACCAH, D
    ALESSI, MC
    SCELLES, V
    MENARD, C
    JUHANVAGUE, I
    VAGUE, P
    [J]. FIBRINOLYSIS, 1993, 7 (03) : 171 - 176
  • [23] REAVEN GM, 1994, J INTERN MED, V236, P13
  • [24] Report of a WHO Study Group, 1985, WHO TECH REP SER
  • [25] Distribution and regulation of plasminogen activator inhibitor-1 in murine adipose tissue in vivo - Induction by tumor necrosis factor-alpha and lipopolysaccharide
    Samad, F
    Yamamoto, K
    Loskutoff, DJ
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1996, 97 (01) : 37 - 46
  • [26] SHAW DA, 1963, LANCET, V1, P352
  • [27] Enhanced expression of PAI-1 in visceral fat: Possible contributor to vascular disease in obesity
    Shimomura, I
    Funahashi, T
    Takahashi, M
    Maeda, K
    Kotani, K
    Nakamura, T
    Yamashita, S
    Miura, M
    Fukuda, Y
    Takemura, K
    Tokunaga, K
    Matsuzawa, Y
    [J]. NATURE MEDICINE, 1996, 2 (07) : 800 - 803
  • [28] SOBEL BE, 1996, CURR OPIN ENDOCRINOL, V3, P355
  • [29] SECRETION OF PLASMINOGEN-ACTIVATOR INHIBITOR-1 FROM CULTURED HUMAN UMBILICAL VEIN ENDOTHELIAL-CELLS IS INDUCED BY VERY LOW-DENSITY-LIPOPROTEIN
    STIKORAHM, A
    WIMAN, B
    HAMSTEN, A
    NILSSON, J
    [J]. ARTERIOSCLEROSIS, 1990, 10 (06): : 1067 - 1073
  • [30] FIBRINOLYTIC VARIABLES ARE RELATED TO AGE, SEX, BLOOD-PRESSURE, AND BODY BUILD MEASUREMENTS - A CROSS-SECTIONAL STUDY IN NORSJO, SWEDEN
    SUNDELL, IB
    NILSSON, TK
    RANBY, M
    HALLMANS, G
    HELLSTEN, G
    [J]. JOURNAL OF CLINICAL EPIDEMIOLOGY, 1989, 42 (08) : 719 - 723